To evaluate the clinical efficacy and safety of Agomelatine in improving symptoms in patients with major depressive disorder (MDD), providing more scientific evidence for the treatment of depression, and offering more effective therapeutic options for patients. Methods A total of 180 MDD patients in ...
RELIEVE中国研究是一项为期24周的多中心前瞻性队列研究,于2018年12月至2020年3月完成入组。受试者来自国内18个研究中心(含精神专科医院及综合医院精神科)的门诊抑郁症患者,年龄≥18岁,当前满足ICD-10抑郁发作诊断标准。排除标准包括...
Major depressive disorder (MDD) (also known as recurrent depressive disorder, clinical depression, major depression, unipolar depression, or unipolar disorder) is a mental disorder characterized by an all-encompassing low mood accompanied by low self-esteem, and by loss of interest or pleasure in ...
TDM is a possible option to improve therapeutic outcomes. The aim of this prospective and naturalistic study was to evaluate the economic and clinical benefit of TDM for depressed inpatients treated with citalopram. Inpatients with MDD according to ICD-10 were included and treated with citalopram. ...
Efforts to develop neuroimaging-based biomarkers in major depressive disorder (MDD), at the individual level, have been limited to date. As diagnostic criteria are currently symptom-based, MDD is conceptualized as a disorder rather than a disease with a